Metraipolis › archive › dc_ac94ca6cd32b

TLR7 agonist, N6-LS and PGT121 delayed viral rebound in SHIV-infected macaques after antiretroviral therapy interruption — Europe PMC PMID:33600506

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/33600506
DOI
10.1371/journal.ppat.1009339
License (as archived)
CC0-1.0
Archived
2026-11-05T21:15:59.931Z
SHA-256 of the archived text
225743d078d38e9b6491df053caaf4a95a9a180380800ea97b2747486b189bd5
Stable URL of this page
https://metraipolis.com/documento/dc_ac94ca6cd32b

How to cite

TLR7 agonist, N6-LS and PGT121 delayed viral rebound in SHIV-infected macaques after antiretroviral therapy interruption — Europe PMC PMID:33600506 — Europe PMC (en), https://europepmc.org/article/MED/33600506 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_ac94ca6cd32b (Metraipolis archive dc_ac94ca6cd32b, sha256 225743d078d38e9b6491df053caaf4a95a9a180380800ea97b2747486b189bd5)
BibTeX
@misc{dcac94ca6cd32b,
  title = {TLR7 agonist, N6-LS and PGT121 delayed viral rebound in SHIV-infected macaques after antiretroviral therapy interruption — Europe PMC PMID:33600506},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/33600506},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_ac94ca6cd32b; sha256 225743d078d38e9b6491df053caaf4a95a9a180380800ea97b2747486b189bd5},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/33600506. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Toll-like receptor 7 (TLR7) agonist and PGT121 (broadly neutralizing antibody, bnAb) administration previously delayed viral rebound and induced SHIV remission. We evaluated the impact of GS-986 (TLR7 agonist) and dual bnAbs on viral rebound after antiretroviral therapy (ART) interruption. Rhesus macaques inoculated with SHIV-1157ipd3N4 were initiated on daily suppressive ART from Day 14 post SHIV inoculation. Active arm animals (n = 8) received GS-986, N6-LS and PGT121 after plasma viral suppression, starting from week 14. GS-986 induced immune activation and SHIV-specific T cell responses but not viral expression in all the active arm animals. After ART interruption, median time to viral rebound was 6 weeks in the active and 3 weeks in the control arm (p = 0.024). In this animal model, the administration of the combination of GS-986 and dual bnAbs was associated with a modest delay in viral rebound. This strategy should be further evaluated to better understand the underlying mechanisms for the induction of virus-specific immune responses and delay in viral rebound.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PLoS pathogens, 2021 (prima pubblicazione 2021-02-18).
Identificativi: PMID 33600506 · PMCID PMC7924766 · DOI 10.1371/journal.ppat.1009339.
Descrittori MeSH principali: Viral Load.
Pagina: https://europepmc.org/article/MED/33600506 — https://doi.org/10.1371/journal.ppat.1009339. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-11-05T21:12:46.048Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.